Modelling human leukemia and lymphoma in severe combined immunodeficient (SCID) mice : Practical applicationsFLAVELL, D. J.Hematological oncology. 1996, Vol 14, Num 2, pp 67-82, issn 0278-0232Article

Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumoursFLAVELL, D. J; FLAVELL, S. U; BOEHM, D. A et al.British journal of cancer. 1995, Vol 72, Num 6, pp 1373-1379, issn 0007-0920Article

Effectiveness of combinations of bispecific antibodies for delivering saporin to human acute T-cell lymphoblastic leukaemia cell lines via CD7 and CD38 as cellular target moleculesFLAVELL, D. J; COOPER, S; MORLAND, B et al.British journal of cancer. 1992, Vol 65, Num 4, pp 545-551, issn 0007-0920Article

Saporin immunotoxinsFLAVELL, D. J.Current Topics in Microbiology and Immunology. 1998, Vol 234, pp 57-61, issn 0070-217XArticle

Therapy of human T-cell acute lymphoblastic leukaemia in severe combined immunodeficient mice with two different anti-CD7-saporin immunotoxins containing hindered or non-hindered disulphide cross-linkersFLAVELL, D. J; BOEHM, D. A; OKAYAMA, K et al.International journal of cancer. 1994, Vol 58, Num 3, pp 407-414, issn 0020-7136Article

Identification of tissue histiocytes on paraffin sections by a new monoclonal antibodyFLAVELL, D. J; JONES, D. B; WRIGHT, D. H et al.The Journal of histochemistry and cytochemistry. 1987, Vol 35, Num 11, pp 1217-1226, issn 0022-1554Article

Systemic therapy with 3BIT, a triple combination cocktail of anti-CD19, -CD22, and -CD38-saporin immunotoxins, is curative of human B-cell lymphoma in severe combined immunodeficient miceFLAVELL, D. J; NOSS, A; PULFORD, K. A. F et al.Cancer research (Baltimore). 1997, Vol 57, Num 21, pp 4824-4829, issn 0008-5472Article

Monoclonal antibody leu-22. RepliesSTROSS, W. P; FLAVELL, D. J; GATTER, K. C et al.American journal of clinical pathology. 1990, Vol 93, Num 2, pp 299-300, issn 0002-9173Article

Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigenBRANDTZAEG, P; JONES, D. B; FLAVELL, D. J et al.Journal of clinical pathology. 1988, Vol 41, Num 9, pp 963-970, issn 0021-9746Article

The anti-mitozantrone monoclonal antibody NO-1, protects acute leukaemia cell lines from the cytotoxic effects of mitozantroneFAVELL, S. U; FLAVELL, D. J.British journal of haematology. 1991, Vol 78, Num 3, pp 330-333, issn 0007-1048Article

The Reed-Sternberg cell/lymphocyte rosette. I: Properties of rosettes formed between Hodgkin's cell lines and allogeneic lymphocytesFLAVELL, D. J; WRIGHT, D. H.British journal of cancer. 1989, Vol 59, Num 2, pp 165-173, issn 0007-0920Article

Development of a sensitive monoclonal antibody-based enzyme-linked immunosorbent assay (ELISA) for mitozantroneFLAVELL, S. U; FLAVELL, D. J.Journal of immunological methods. 1988, Vol 115, Num 2, pp 179-185, issn 0022-1759, 7 p.Article

Opisthorchis viverrini: Pathogenesis of infection in immunodeprived hamstersFLAVELL, D. J; FLAVELL, S. U.Parasite immunology. 1986, Vol 8, Num 5, pp 455-466, issn 0141-9838Article

Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T-cell acute lymphoblastic leukemia cell lineFLAVELL, D. J; COOPER, S; OKAYAMA, K et al.Hematological oncology. 1995, Vol 13, Num 4, pp 185-200, issn 0278-0232Article

Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428. cancer res., 48 : 37-40, 1988. ReplyFLAVELL, D. J; WRIGHT, D. H; SANDERS, M. E et al.Cancer research (Baltimore). 1990, Vol 50, Num 10, pp 3131-3132, issn 0008-5472, 2 p.Article

Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigenSTROSS, W. P; WARNKE, R. A; FLAVELL, D. J et al.Journal of clinical pathology. 1989, Vol 42, Num 9, pp 953-961, issn 0021-9746, 9 p.Article

Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxinFLAVELL, D. J; BOEHM, D. A; NOSS, A et al.British journal of cancer. 2001, Vol 84, Num 4, pp 571-578, issn 0007-0920Article

Host-mediated antibody-dependent cellular cytotoxicity contributes to the in vivo therapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemiaFLAVELL, D. J; WARNES, S; NOSS, A et al.Cancer research (Baltimore). 1998, Vol 58, Num 24, pp 5787-5794, issn 0008-5472Article

Therapy of human B-cell lymphoma bearing SCID mice is more effective with anti-CD19- and anti-CD38-SAPORIN immunotoxins used in combination than with either immunotoxin used aloneFLAVELL, D. J; BOEHM, D. A; EMERY, L et al.International journal of cancer. 1995, Vol 62, Num 3, pp 337-344, issn 0020-7136Article

High-dose mitoxantrone and etoposide conditioning in autologous bone marrow transplantation for relapsed Hodgkin's diseaseLIM, S. H; BAGLIN, T. P; FLAVELL, D. J et al.European journal of haematology. 1992, Vol 48, Num 2, pp 110-114, issn 0902-4441Article

Anti-CD7 antibody and immunotoxin treatment of human CD7⁺ T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid miceFLAVELL, D. J; WARNES, S. L; NOSS, A. L et al.British journal of cancer. 2000, Vol 83, Num 12, pp 1755-1761, issn 0007-0920Article

Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin moleculeFLAVELL, D. J; BOEHM, D. A; NOSS, A et al.British journal of cancer. 1997, Vol 75, Num 7, pp 1035-1043, issn 0007-0920Article

Effectiveness of HB2 (anti-CD7) : saporin immunotoxin in an in vivo model of human T-cell leukamia developed in severe combined immunodeficient miceMORLAND, B. J; BARLEY, J; BOEHM, D et al.British journal of cancer. 1994, Vol 69, Num 2, pp 279-285, issn 0007-0920Article

Characterization of a stem cell glycoprotein expressed by basal keratinocytesKELLY, S. E; VITTIE, E. M. C; JONES, D. B et al.EJD. European journal of dermatology. 1992, Vol 2, Num 6, pp 424-428Article

Characteristics and performance of a bispecific F (ab'γ)₂ antibody for delivering saporin to a CD7⁺ human acute T-cell leukaemia cell lineFLAVELL, D. J; COOPER, S; MORLAND, B et al.British journal of cancer. 1991, Vol 64, Num 2, pp 274-280, issn 0007-0920Article